Squamous Cell Carcinoma of the Oral Cavity, Larynx, Oropharynx and Hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up
Annals of Oncology
Machiels, J. P., René Leemans, C., et al. (2020).
Annals of Oncology, 31(11), 1462-1475.
This guideline provides recommendations on the management of patients with squamous cell carcinoma of the oral cavity, larynx, oropharynx, and hypopharynx.
European Head and Neck Society (EHNS); European Society for Medical Oncology (ESMO); European SocieTy for Radiotherapy & Oncology (ESTRO)
<div>Clinical follow-up, including head and neck examination by flexible endoscopy, should be carried out every two to three months during the first two years, every six months between years three to five, and annually thereafter (Level III; Grade A). Follow-up should include the whole head and neck multidisciplinary team, including the physician, dietician, speech-swallowing-hearing specialist, and psychological specialist (Ungraded).</div>
